Evidence map›Paper›PMID 32350553›Full record

ReviewCellular and molecular life sciences : CMLS2020

Transcriptional regulation of Treg homeostasis and functional specification.

Ke Wang, Wenxian Fu

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Immune Cells in Preeclampsia.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Salvianolic acid A enhances TArchives of pharmacal research · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. An integrated transcription factor framework for Treg identity and diversity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Radiotherapy combined with immunotherapy: the dawn of cancer treatment.Signal transduction and targeted therapy · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ke WangPediatric Diabetes Research Center, Department of Pediatrics, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Wenxian FuPediatric Diabetes Research Center, Department of Pediatrics, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. w3fu@ucsd.edu.ORCID http://orcid.org/0000-0003-0684-8929

Funding

Treg homeostatic differentiation and maintenanceR56AI139753 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LU, LI-FAN · 2019 to 2019
$381k
NIAID NIH HHS R56 AI139753NIH HHS AI139753
6 · The paper itself

Abstract

CD4

Indexed as

Transcriptional ActivationAnimalsEpigenesis, GeneticHumansInflammationSignal TransductionT-Lymphocytes, RegulatoryTranscription FactorsTranscription FactorsCofactorHomeostasisLEF1PrecursorTCF1Treg

Identifiers

PMID32350553
PMCPMC7606275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.